Elevated levels of monocyte chemoattractant protein-1 in the aqueous humor after phacoemulsification

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 13, 2012, Pages 7951-7960

  Kawai, Motofumi ^a,b   Inoue, Toshihiro ^a   Inatani, Masaru ^a,c   Tsuboi, Naoko ^a,b   Shobayashi, Kohei ^a   Matsukawa, Akihiro ^d   Yoshida, Akitoshi ^b   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR AA; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CATARACT; CILIARY BODY; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; IRIS; LENS IMPLANTATION; MALE; NONHUMAN; PHACOEMULSIFICATION; POSTERIOR LENS CAPSULE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; ANIMALS; AQUEOUS HUMOR; CELLS, CULTURED; CHEMOKINE CCL2; CILIARY BODY; CORNEA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; HUMANS; INTERLEUKIN-8; IRIS; LENS CAPSULE, CRYSTALLINE; LENS IMPLANTATION, INTRAOCULAR; LENS, CRYSTALLINE; MALE; MIDDLE AGED; PHACOEMULSIFICATION; PLATELET-DERIVED GROWTH FACTOR; POSTOPERATIVE PERIOD; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84870556371     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10231     Document Type: Article

References (58)

1. Shah SM, Spalton DJ. Changes in anterior chamber flare and cells following cataract surgery. Br J Ophthalmol. 1994;78:91-94.
2. Wallentin N, Wickstrom K, Lundberg C. Effect of cataract surgery on aqueous TGF-beta and lens epithelial cell proliferation. Invest Ophthalmol Vis Sci. 1998;39:1410-1418.
3. Taravati P, Lam DL, Leveque T, Van Gelder RN. Postcataract surgical inflammation. Curr Opin Ophthalmol. 2012;23:12-18.
4. Findl O, Amon M, Petternel V, Kruger A. Early objective assessment of intraocular inflammation after phacoemulsifica-tion cataract surgery. J Cataract Refract Surg. 2003;29:2143-2147.
5. Alio JL, Sayans JA, Chipont E. Laser flare-cell measurement of inflammation after uneventful extracapsular cataract extraction and intraocular lens implantation. J Cataract Refract Surg. 1996;22(suppl 1):775-779.
6. Schauersberger J, Kruger A, Mullner-Eidenbock A, et al. Long-term disorders of the blood-aqueous barrier after small-incision cataract surgery. Eye (Lond). 2000;14(pt 1):61-63.
7. Van Buskirk EM. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol. 1996;122:751-752.
8. Gross RL, Feldman RM, Spaeth GL, et al. Surgical therapy of chronic glaucoma in aphakia and pseudophakia. Ophthalmology. 1988;95:1195-1201.
9. Bellows AR, Johnstone MA. Surgical management of chronic glaucoma in aphakia. Ophthalmology. 1983;90:807-813.
10. Minassian DC, Rosen P, Dart JK, et al. Extracapsular cataract extraction compared with small incision surgery by phaco-emulsification: a randomised trial. Br J Ophthalmol. 2001;85: 822-829.
11. Takihara Y, Inatani M, Seto T, et al. Trabeculectomy with mitomycin for open-angle glaucoma in phakic vs pseudo-phakic eyes after phacoemulsification. Arch Ophthalmol. 2011;129:152-157.
12. Awai-Kasaoka N, Inoue T, Takihara Y, et al. Impact of phacoemulsification on failure of trabeculectomy with mito-mycin-C. J Cataract Refract Surg. 2012;38:419-424.
13. Inoue T, Kawaji T, Inatani M, Kameda T, Yoshimura N, Tanihara H. Simultaneous increases in multiple proinflammatory cytokines in the aqueous humor of pseudophakic glaucoma-tous eyes. J Cataract Refract Surg. 2012;38:1389-1397.
14. Nishi O, Nishi K, Ohmoto Y. Effect of interleukin 1 receptor antagonist on the blood-aqueous barrier after intraocular lens implantation. Br J Ophthalmol. 1994;78:917-920.
15. DiPietro LA, Burdick M, Low QE, Kunkel SL, Strieter RM. MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. J Clin Invest. 1998;101:1693-1698.
16. Weber KS, Nelson PJ, Grone HJ, Weber C. Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothe-lium. Arterioscler Thromb Vasc Biol. 1999;19:2085-2093.
17. Matsukawa A, Miyazaki S, Maeda T, et al. Production and regulation of monocyte chemoattractant protein-1 in lipopoly-saccharide- or monosodium urate crystal-induced arthritis in rabbits: roles of tumor necrosis factor alpha, interleukin-1, and interleukin-8. Lab Invest. 1998;78:973-985.
18. Trivedi RH, Nutaitis M, Vroman D, Crosson CE. Influence of race and age on aqueous humor levels of transforming growth factor-beta 2 in glaucomatous and nonglaucomatous eyes. J Ocul Pharmacol Ther. 2011;27:477-480.
19. Kuchtey J, Rezaei KA, Jaru-Ampornpan P, Sternberg P Jr, Kuchtey RW. Multiplex cytokine analysis reveals elevated concentration of interleukin-8 in glaucomatous aqueous humor. Invest Ophthalmol Vis Sci. 2010;51:6441-6447.
20. Takai Y, Tanito M, Ohira A. Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract. Invest Ophthalmol Vis Sci. 2012;53:241-247.
21. Balaiya S, Edwards J, Tillis T, Khetpal V, Chalam KV. Tumor necrosis factor-alpha (TNF-alpha) levels in aqueous humor of primary open angle glaucoma. Clin Ophthalmol. 2011;5:553-556.
22. Inatani M, Tanihara H, Katsuta H, Honjo M, Kido N, Honda Y. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch Clin Exp Ophthalmol. 2001; 239:109-113.
23. Picht G, Welge-Luessen U, Grehn F, Lutjen-Drecoll E. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol. 2001;239: 199-207.
24. Borazan M, Karalezli A, Kucukerdonmez C, et al. Aqueous humor and plasma levels of vascular endothelial growth factor and nitric oxide in patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. J Glaucoma. 2010;19:207- 211.
25. Chua J, Vania M, Cheung CM, et al. Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes. Mol Vis. 2012;18:431-438.
26. El-Asrar AM, Struyf S, Kangave D, et al. Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin Immunol. 2011;139:177-184.
27. Lindstedt EW, Baarsma GS, Kuijpers RW, van Hagen PM. Anti-TNF-alpha therapy for sight threatening uveitis. Br J Oph-thalmol. 2005;89:533-536.
28. Sijssens KM, Rijkers GT, Rothova A, Stilma JS, Schellekens PA, de Boer JH. Cytokines, chemokines and soluble adhesion molecules in aqueous humor of children with uveitis. Exp Eye Res. 2007;85:443-449.
29. Sugita S, Takase H, Taguchi C, Mochizuki M. The role of soluble TNF receptors for TNF-alpha in uveitis. Invest Ophthalmol Vis Sci. 2007;48:3246-3252.
30. Yoshida Y, Yamagishi S, Ueda S, Yoshimura K, Okuda S, Yamakawa R. Aqueous humor levels of asymmetric dimethy-larginine (ADMA) are positively associated with monocyte chemoattractant protein-1 (MCP-1) in patients with uveitis. Br J Ophthalmol. 2008;92:93-94.
31. van Kooij B, Rothova A, Rijkers GT, de Groot-Mijnes JD. Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema. Am J Ophthalmol. 2006;142:192-194.
32. Takase H, Futagami Y, Yoshida T, et al. Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. Invest Ophthalmol Vis Sci. 2006;47: 1557-1561.
33. Ongkosuwito JV, Feron EJ, van Doornik CE, et al. Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci. 1998;39: 2659-2665.
34. Ooi KG, Galatowicz G, Towler HM, Lightman SL, Calder VL. Multiplex cytokine detection versus ELISA for aqueous humor: IL-5, IL-10, and IFNgamma profiles in uveitis. Invest Oph-thalmol Vis Sci. 2006;47:272-277.
35. Kramer M, Hasanreisoglu M, Feldman A, et al. Monocyte chemoattractant protein-1 in the aqueous humor of patients with age-related macular degeneration. Clin Experiment Ophthalmol. 2011;In press.
36. Jonas JB, Tao Y, Neumaier M, Findeisen P. Monocyte chemo-attractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch Ophthalmol. 2010;128:1281-1286.
37. Roh MI, Lim SJ, Ahn JM, Lim JB, Kwon OW. Concentration of cytokines in age-related macular degeneration after consecutive intravitreal bevacizumab injection. Graefes Arch Clin Exp Ophthalmol. 2010;248:635-640.
38. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994; 118:445-450.
39. Patel JI, Tombran-Tink J, Hykin PG, Gregor ZJ, Cree IA. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinop-athy patients with macular edema: Implications for structural differences in macular profiles. Exp Eye Res. 2006;82:798-806.
40. Funatsu H, Yamashita H, Noma H, et al. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol. 2005;243:3-8.
41. Funatsu H, Yamashita H, Noma H, Mimura T, Yamashita T, Hori S. Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol. 2002;133:70-77.
42. Shinoda K, Ishida S, Kawashima S, et al. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy. Curr Eye Res. 2000;21:655-661.
43. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994; 331:1480-1487.
44. Oh IK, Kim SW, Oh J, Lee TS, Huh K. Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy. Curr Eye Res. 2010;35:1116-1127.
45. Funk M, Schmidinger G, Maar N, et al. Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab. Retina. 2010;30:1412-1419.
46. Sohn HJ, Han DH, Kim IT, et al. Changes in aqueous concentrations of various cytokines after intravitreal triamcin-olone versus bevacizumab for diabetic macular edema. Am J Ophthalmol. 2011;152:686-694.
47. Arimura N, Otsuka H, Yamakiri K, et al. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy. Ophthalmology. 2009;116:921-926.
48. Park SP, Ahn JK. Changes of aqueous vascular endothelial growth factor and interleukin-6 after intravitreal triamcinolone for branch retinal vein occlusion. Clin Experiment Ophthal-mol. 2008;36:831-835.
49. Shrivastava A, Singh K. The effect of cataract extraction on intraocular pressure. Curr Opin Ophthalmol. 2010;21:118-122.
50. Frezzotti R, Caporossi A, Mastrangelo D, et al. Pathogenesis of posterior capsular opacification. Part II: histopathological and in vitro culture findings. J Cataract Refract Surg. 1990;16: 353-360.
51. Wormstone IM. Posterior capsule opacification: a cell biological perspective. Exp Eye Res. 2002;74:337-347.
52. Saika S, Miyamoto T, Tanaka T, Ishida I, Ohnishi Y, Ooshima A. Latent TGFbeta binding protein-1 and fibrillin-1 in human capsular opacification and in cultured lens epithelial cells. Br J Ophthalmol. 2001;85:1362-1366.
53. Wormstone IM, Tamiya S, Anderson I, Duncan G. TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Invest Ophthalmol Vis Sci. 2002; 43:2301-2308.
54. Saika S, Yamanaka O, Okada Y, et al. TGF beta in fibroprolifer-ative diseases in the eye. Front Biosci (Schol Ed). 2009;1:376-390.
55. Takahashi E, Nagano O, Ishimoto T, et al. Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction. J Biol Chem. 2010;285:4060-4073.
56. Cousins SW, McCabe MM, Danielpour D, Streilein JW. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Oph-thalmol Vis Sci. 1991;32:2201-2211.
57. Granstein RD, Staszewski R, Knisely TL, et al. Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation. J Immunol. 1990;144:3021-3027.
58. Jampel HD, Roche N, Stark WJ, Roberts AB. Transforming growth factor-beta in human aqueous humor. Curr Eye Res. 1990;9:963-969.